Research Article
The Association of the Immune Response Genes to Human Papillomavirus-Related Cervical Disease in a Brazilian Population
Table 6
HLA haplotype frequencies with significant differences between HPV patients and controls.
| Haplotypes | Patients (hf) | Controls (hf) | | OR | CI |
| HLA-A*02–HLA-B*51 | 1 (0.006) | 16 (0.052) | 0.006 | 0.1186 | 0.015–0.8717 | HLA-A*03–HLA-DRB1*11 | 7 (0.043) | 1 (0.003) | 0.002 | 150.828 | 1.712–115.230 | HLA-B*14–HLA-DRB1*13 | 5 (0.032) | 1 (0.003) | 0.017 | 108.906 | 1.146–85.504 | HLA-B*15–HLA-DRB1*07 | 5 (0.029) | 1 (0.003) | 0.017 | 108.906 | 1.146–85.505 | HLA-B*15–HLA-DRB1*11 | 7 (0.048) | 1 (0.003) | 0.002 | 150.828 | 1.712–115.230 | HLA-B*44–HLA-DRB1*01 | 6 (0.036) | 2 (0.005) | 0.018 | 49.028 | 1.188–29.885 | HLA-B*44–HLA-DRB1*11 | 7 (0.048) | 1 (0.003) | 0.002 | 150.828 | 1.712–115.230 |
|
|
: haplotype numbers; hf: haplotype frequencies (%); : value; OR: odds ratio; CI (95%): 95% confidence interval.
|